COCH Earnings

Quarterly EPS
$-3.97
Q4 2024
$-2.90
Q1 2025
$-3.20
Q2 2025
$-3.55
Q3 2025
$-2.72
Q4 2025
$-0.80
Q1 2026
$-0.70
Q2 2026
$-0.50
Q3 2026
Latest Revenue66.0K
Latest Net Income-3932000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.5066.0K-3932000+57.1%+85.9%
Q2 2026-$0.7051.0K-5982000-34.6%+78.1%
Q1 2026-$0.8039.0K-4351000-15.2%+72.4%
Q4 2025-$2.7275.0K-6586000+78.6%+31.5%
Q3 2025-$3.5542.0K-6482000-25.0%+9.0%
Q2 2025-$3.2078.0K-5690000+14.7%-10.3%
Q1 2025-$2.9046.0K-4998000-22.0%+29.3%
Q4 2024-$3.9742.0K-4618000-55.8%-18.9%
Q3 2024-$3.9056.0K-5960000——
Q2 2024-$2.9068.0K-3947000——
Q1 2024-$4.1059.0K-6270000——
Q4 2023-$3.3495.0K-4895000——
Envoy Medical (COCH) — Earnings